4-2085646-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181808.4(POLN):c.2164G>A(p.Ala722Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181808.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POLN | NM_181808.4 | c.2164G>A | p.Ala722Thr | missense_variant | 21/26 | ENST00000511885.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POLN | ENST00000511885.6 | c.2164G>A | p.Ala722Thr | missense_variant | 21/26 | 5 | NM_181808.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251450Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135908
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461768Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727184
GnomAD4 genome AF: 0.000145 AC: 22AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.2164G>A (p.A722T) alteration is located in exon 19 (coding exon 19) of the POLN gene. This alteration results from a G to A substitution at nucleotide position 2164, causing the alanine (A) at amino acid position 722 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at